(Press-News.org) EAST LANSING, Mich. - Researchers at Michigan State University were part of a team to discover a new natural defense against HIV infection.
The team's discovery, featured in the current issue of the Journal of Biological Chemistry, focuses on ERManI, a protein that prevents the HIV virus from replicating.
"In earlier studies, we knew that we could interfere with the spread of HIV-1, but we couldn't identify the mechanism that was stopping the process," said Yong-Hui Zheng, MSU associate professor of microbiology and molecular genetics and co-author of the study. "We now know that ERManI is an essential key, and that it has the potential as a antiretroviral treatment."
Antiretroviral treatments are not vaccines; they simply keep HIV in check in low levels in the body. While it could be decades before an ERManI-based treatment can be prescribed for HIV-1 patients, these results provide a strong path for future research involving human cells, and later, clinical tests.
The next steps will be to test if HIV resistance can be promoted by increasing ERManI levels, said Zheng, who worked on the study with scientists from the Harbin Veterinary Research Institute, the Chinese Academy of Agricultural Sciences and the University of Georgia.
Most viruses have viral envelopes, or protective skins, that comprise similar building blocks of the host the pathogens are trying to infect. On the surface of the envelope, there are viral glycoproteins, known as Env spikes, which act as valets, leading viruses to binding sites that allow infections to spread at the molecular level. They serve as a key of sorts that gives viruses entry into the host to begin spreading.
Zheng's lab was the first to show that HIV-1 envelope glycoprotein biosynthesis can be specifically inhibited by ERManI, which is a host enzyme to add sugars to proteins. By identifying ERManI as the target that slows the spread of HIV-1, the team has revealed a target in which future natural therapies can be developed.
More than 1.2 million people in the United States have HIV. In China, doctors diagnosed 104,000 new cases of HIV/AIDS in 2014. The number of infections is rising, though overall the country still has a low rate of infection.
Currently, there is no cure for HIV-1; once patients have it, they have it for life. While there are antiretroviral therapies available, they can only prolong life, albeit dramatically, but they cannot cure the disease. Current drug treatments have to be taken for a lifetime, which causes side effects and many other issues, Zheng said.
"We see a way to treat this disease by helping the body protect itself," he said. "That's why we continue to move our research forward, seemingly slowly at times, because finding a cure will take years. We feel that's it's important enough, on a world-wide scale, to dedicate our work to fighting this disease."
INFORMATION:
This research was funded in part by the National Institutes of Health.
Michigan State University has been working to advance the common good in uncommon ways for more than 150 years. One of the top research universities in the world, MSU focuses its vast resources on creating solutions to some of the world's most pressing challenges, while providing life-changing opportunities to a diverse and inclusive academic community through more than 200 programs of study in 17 degree-granting colleges.
For MSU news on the Web, go to MSUToday. Follow MSU News on Twitter at twitter.com/MSUnews.
NEW YORK - September 16, 2015 - EcoHealth Alliance, an environmental health nonprofit organization that focuses on local conservation and global health issues, announced the creation of the first centralized repository to collect data on the biological diversity in Bolivia. EcoHealth Alliance Senior Scientist, Carlos Zambrana-Torrelio, in collaboration with Miguel Fernandez from the German Centre for Integrative Biodiversity Research in coordination with more than 40 Bolivian scientists worked together to create the unique repository. The value of a biological repository ...
LAWRENCE -- A new study based on longitudinal data confirms a college degree provides an advantage in lifetimes earnings, but a related decision once students make it to college could prove to be even more crucial.
The study that includes a University of Kansas researcher found large lifetime earnings gaps depending on a student's field of study. For examples, men who major in science, technology, engineering and mathematics, or STEM fields, and earning a bachelor's degree achieved roughly $700,000 to $800,000 higher 40-year lifetime earnings from ages 20 to 59 than social ...
The incidence of the most common strain of Methicillin-resistant Staphylococcus aureus (MRSA) infections has decreased in hospital-onset cases, but has failed to decline in the broader community, according to new research published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
The USA 300 strain of MRSA, has become prevalent in both communities and healthcare institutions. "In looking at risk factors for hospital or community-onset USA 300, current or former drug use was a strong predictor ...
Amsterdam, September 16, 2015 - Targeted cancer treatments, toxicity sensors and living factories: synthetic biology has the potential to revolutionize science and medicine. But before the technology is ready for real-world applications, more attention needs to be paid to its safety and stability, say experts in a review article published in Current Opinion in Chemical Biology.
Synthetic biology involves engineering microbes like bacteria to program them to behave in certain ways. For example, bacteria can be engineered to glow when they detect certain molecules, and ...
Washington -- A new analysis by the Synthetic Biology Project at the Wilson Center finds the Defense Department and its Defense Advanced Research Projects Agency (DARPA) funds much of the U.S. government's research in synthetic biology, with less than 1 percent of total federal funding going to risk research.
The report, U.S. Trends in Synthetic Biology Research, finds that between 2008 and 2014, the United States invested approximately $820 million dollars in synthetic biology research. In that time period, the Defense Department became a key funder of synthetic biology ...
The first true three-dimensional picture of submarine canyon habitats has been produced using a unique combination of marine robotics and ship-based measurements. The information captured in this new set of maps ranges in scale from the 200km canyon down to the size of an individual cold-water coral polyp, and will be used to inform the management of the only English Marine Conservation Zone in deep water.
This 'nested map' is the result of a recent scientific expedition to the Whittard Canyon in the Bay of Biscay, led by the National Oceanography Centre (NOC). It works ...
ROCHESTER, Minn. - Mayo Clinic researchers have identified a protein marker whose frequency may predict patient response to PD-1 blockade immunotherapy for melanoma. An abstract of their findings was presented today at the American Association for Cancer Research International Cancer Immunotherapy Conference in New York City.
"The discovery of biomarkers of sensitivity are vital not only for informing clinical decisions, but also to help identify which patients with melanoma, and possibly other malignancies, who are most likely to benefit from PD-1 blockade," says Roxana ...
The oil and gas extraction method called hydraulic fracturing remains controversial for multiple reasons, one of which is its water use. But, as scientists report in ACS' journal Environmental Science & Technology Letters, water requirements for the process are potentially lower than those for some other energy-related extraction methods.
Since oil and gas companies ramped up hydraulic fracturing, or fracking, to unlock oil and gas from shale and tight oil formations, reports of earthquakes and contaminated water near wells proliferated. Some environmental experts have ...
Detecting breast cancer in women with dense mammary tissues could become more reliable with a new mammogram procedure that researchers have now tested in pre-clinical studies of mice. In their report in the journal ACS Nano, they describe injecting gold nanoparticles in mammary tissue to enhance the imaging of early signs of breast cancer.
Mammography remains the clinical gold standard of screening tests for detecting breast cancer. However, a recognized limitation of this X-ray procedure is that dense breast tissue shows up as white masses and fibers on an image, ...
Citizen science is taking off and could make a difference at regional and national regulatory levels. But not everyone thinks that's a good idea. The cover story of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, delves into the progress of the budding movement, as well as the pushback.
Steven K. Gibb, senior editor at C&EN, reports that in some states, regulators actively encourage and support local residents' participation in environmental monitoring. For example, Maryland's Department of the Environment and Department ...
